High Tower Advisors, LLC Cerus Corp Transaction History

High Tower Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$4.79 - $6.68 $68,808 - $95,958	-14,365 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$5.68 - $7.87 $5,680 - $7,870	-1,000 Reduced 6.51%	14,365 $86,000
Q4 2020 Feb 10, 2021	BUY	$5.25 - $8.56 $12,416 - $20,244	2,365 Added 18.19%	15,365 $107,000
Q3 2020 Nov 13, 2020	SELL	$5.78 - $7.47 $15,264 - $19,728	-2,641 Reduced 16.89%	13,000 $82,000
Q2 2020 Aug 10, 2020	BUY	$4.5 - $7.02 $13,500 - $21,060	3,000 Added 23.73%	15,641 $103,000
Q1 2020 May 21, 2020	BUY	$2.87 - $5.49 $36,279 - $69,399	12,641 New	12,641 $59,000
Q4 2019 Feb 14, 2020	SELL	$3.84 - $4.86 $59,139 - $74,848	-15,401 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$4.86 - $6.05 $12,835 - $15,978	2,641 Added 20.7%	15,401 $80,000
Q2 2019 Aug 13, 2019	BUY	$4.51 - $6.6 $4,510 - $6,600	1,000 Added 8.5%	12,760 $72,000
Q4 2018 Feb 14, 2019	BUY	$4.89 - $7.16 $4,890 - $7,160	1,000 Added 9.29%	11,760 $59,000
Q3 2018 Nov 09, 2018	BUY	$6.89 - $7.78 $74,136 - $83,712	10,760 New	10,760 $78,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.